Results 121 to 130 of about 77,915 (259)

The impact of the COVID-19 pandemic on patients with systemic vasculitis: a single-centre retrospective study. [PDF]

Rheumatol Int, 2023
Auanassova A, Yessirkepov M, Zimba O.
europepmc   +1 more source

Histopathologic Characterization of Cutaneous Oxalosis Mimicking Calciphylaxis: Diagnostic Pitfalls and Polarized Light Evaluation

Journal of Cutaneous Pathology, EarlyView.
ABSTRACT Cutaneous oxalosis is an uncommon manifestation of primary hyperoxalosis, which can often resemble other cutaneous manifestations of end stage renal disease (ESRD), particularly calciphylaxis. We report the case of a 46 year old female with primary hyperoxaluria type one (PH1) believed to be well‐controlled on lumasiran, a small interfering ...
Shrina Patel, Brad Graham, Kaci Reaves, Mya Phelps   +3 more
wiley   +1 more source

Clinical Remission and Reduction of Circulating Nephritic Factors by Combining Rituximab With Belimumab in a Case of Complement Factor 3 Glomerulopathy

Kidney International Reports
Mieke van Schaik, Aiko P.J. de Vries, Frederike J. Bemelman, Ton J. Rabelink, Leendert A. Trouw, Cees van Kooten, Yoe Kie Onno Teng   +6 more
doaj   +1 more source

Ruxolitinib reverses systemic vasculitis driven by JAK2 V617F-mutated essential thrombocythemia: a case report. [PDF]

Front Immunol
Ashida Y, Ota S, Ishidoya N, Murai Y, Amenomori K, Hasui K, Kawaguchi S, Yamaguchi S, Hiraga H, Kamata K, Ichikawa H, Tomita H, Yu Z, Minakawa M, Sakuraba H.   +14 more
europepmc   +1 more source

Risk of systemic vasculitis following mRNA COVID-19 vaccination: a pharmacovigilance study. [PDF]

Rheumatology (Oxford), 2022
Mettler C, Terrier B, Treluyer JM, Chouchana L.   +3 more
europepmc   +1 more source

Cyclophosphamide is associated with long‐term treatment‐free remission in patients with pemphigus

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Background and objective Pemphigus treatment has seen significant advancements, yet long‐term remission remains a challenge. Comparative data on the long‐term effectiveness of available therapies are limited. We compared 10‐year relapse rates in pemphigus patients treated with azathioprine or cyclophosphamide plus high‐dose IV corticosteroids ...
Bettina Santler, Simon Lüdtke, Lena Dietze, Marie Schiffmann, Dominik Straube, Jan Ehrchen   +5 more
wiley   +1 more source

Editorial: Community series: systemic vasculitis: advances in pathogenesis and therapies, volume II. [PDF]

Front Immunol
De Souza AWS, Ooi JD, Deng J, Croci S, Gan PY, Brown KL.   +5 more
europepmc   +1 more source

Case Report: Interventional therapy for portal venous stenosis caused by systemic vasculitis. [PDF]

Front Immunol, 2022
Cai Q, Wei B, Tai Y, Wu H.
europepmc   +1 more source

Diagnosis and treatment of systemic vasculitis: Case report and literature review. [PDF]

Medicine (Baltimore)
Liu A, Wang L, Li H, Meng Y.
europepmc   +1 more source

Association Between Systemic Vasculitis and Coronary Microvascular Dysfunction in the Absence of Obstructive Coronary Artery Disease. [PDF]

Circ Cardiovasc Imaging, 2023
Weber B, Wallace ZS, Parks S, Cook C, Huck DM, Garshick M, Brown JM, Divakaran S, Hainer J, Dorbala S, Blankstein R, Liao KP, Aghayev A, Choi HK, Di Carli M.   +14 more
europepmc   +1 more source